Section Arrow
AKTX.NASDAQ
- Akari Therapeutics plc
(Financial Status)
Quotes are at least 15-min delayed:2024/05/16 13:08 EDT
Last
 1.53
+0.07 (+4.79%)
Day High 
1.72 
Prev. Close
1.46 
1-M High
1.8676 
Volume 
3.43K 
Bid
1.44
Ask
1.64
Day Low
1.44 
Open
1.44 
1-M Low
1.0775 
Market Cap 
11.57M 
Currency USD 
P/E -- 
%Yield
10-SMA 1.48 
20-SMA 1.38 
50-SMA 1.58 
52-W High 5.5 
52-W Low 1.0775 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.04/-3.60
Enterprise Value
11.57M
Balance Sheet
Book Value Per Share
-0.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1015+0.0238+30.63%-- 
DNAGinkgo Bioworks Holdings0.8481+0.009+1.07%-- 
JAGXJaguar Health0.2808+0.0257+10.07%-- 
NBYNovaBay Pharmaceuticals0.1076+0.0031+2.97%-- 
NVAXNovavax13.15+0.25+1.94%-- 
Quotes are at least 15-min delayed:2024/05/16 13:08 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.